Haemonetics Stock Target Price and Analyst Consensus

HAE Stock  USD 65.52  0.41  0.62%   
The current analyst and expert consensus on Haemonetics is Strong Buy, with 3 strong buy opinions. The current projected Haemonetics target price consensus is 110.80 with 10 analyst opinions. Check out Macroaxis Advice on Haemonetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.
The most common way Haemonetics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Haemonetics executives and customers to further validate their buy or sell advice. Haemonetics buy-or-sell recommendation module provides average expert sentiment on the projected Haemonetics target price to derive its highest and lowest estimates based on projected price volatility of 2.6894.
Lowest Forecast
100.83
Highest Forecast
122.99
Target Price
110.8
At present, Haemonetics' Pretax Profit Margin is projected to increase slightly based on the last few years of reporting. The current year's Net Profit Margin is expected to grow to 0.08, whereas Operating Profit Margin is forecasted to decline to 0.06. At present, Haemonetics' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 224.1 M, whereas Retained Earnings are forecasted to decline to about 281.9 M.
  
It's important to approach Haemonetics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Haemonetics Target Price Consensus

Haemonetics target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Haemonetics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   10  Strong Buy
Most Haemonetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Haemonetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Haemonetics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Haemonetics Target Price Projection

Haemonetics' current and average target prices are 65.52 and 110.80, respectively. The current price of Haemonetics is the price at which Haemonetics is currently trading. On the other hand, Haemonetics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Haemonetics Market Quote on 15th of March 2025

Low Price65.28Odds
High Price67.03Odds

65.52

Target Price

Analyst Consensus On Haemonetics Target Price

Low Estimate100.83Odds
High Estimate122.99Odds

110.8

Historical Lowest Forecast  100.83 Target Price  110.8 Highest Forecast  122.99
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Haemonetics and the information provided on this page.

Haemonetics Analyst Ratings

Haemonetics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Haemonetics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Haemonetics' financials, market performance, and future outlook by experienced professionals. Haemonetics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Haemonetics price targets

Haemonetics' stock target price is an estimate of its future price, usually made by analysts. Using Haemonetics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Haemonetics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Haemonetics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Haemonetics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Haemonetics is a key component of Haemonetics valuation and have some predictive power on the future returns of a Haemonetics.
Hype
Prediction
LowEstimatedHigh
62.7965.4868.17
Details
Intrinsic
Valuation
LowRealHigh
58.9784.8887.57
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.121.141.16
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Haemonetics. Your research has to be compared to or analyzed against Haemonetics' peers to derive any actionable benefits. When done correctly, Haemonetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Haemonetics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 60 shares
Cash Cows Idea
Cash Cows
Invested few shares
Apparel Idea
Apparel
Invested over 40 shares
Casinos Idea
Casinos
Sold over 90 shares
Macroaxis Index Idea
Macroaxis Index
Sold over 90 shares
Utilities Idea
Utilities
Invested over 90 shares
When determining whether Haemonetics is a strong investment it is important to analyze Haemonetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Haemonetics' future performance. For an informed investment choice regarding Haemonetics Stock, refer to the following important reports:
Check out Macroaxis Advice on Haemonetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Please note, the presentation of Haemonetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Haemonetics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Haemonetics' management manipulating its earnings.